Clinical Study for the Effect of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 01 Feb 2019
Price : $35 *
At a glance
- Drugs Teneligliptin (Primary) ; Antihyperglycaemics
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms TOPLEVEL
- 31 Aug 2018 Biomarkers information updated
- 20 Aug 2018 Planned primary completion date changed from 1 Jun 2019 to 1 Jun 2020.
- 26 Jun 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.